Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

about

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q55504502

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@en

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@nl

type

Item

label

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@en

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@nl

prefLabel

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@en

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@nl

P1476

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.

@en

P2093

Arthur Branstrom

http://www.w3.org/2001/XMLSchema#string

Aya Maeda

http://www.w3.org/2001/XMLSchema#string

Jo Ishizawa

http://www.w3.org/2001/XMLSchema#string

Kensuke Kojima

http://www.w3.org/2001/XMLSchema#string

Kosei Matsue

http://www.w3.org/2001/XMLSchema#string

Liangxian Cao

http://www.w3.org/2001/XMLSchema#string

Mariko Yoshimura

http://www.w3.org/2001/XMLSchema#string

Marla Weetall

http://www.w3.org/2001/XMLSchema#string

Shinya Kimura

http://www.w3.org/2001/XMLSchema#string

Takenobu Nii

http://www.w3.org/2001/XMLSchema#string

P2860

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1

Clonal evolution in hematological malignancies and therapeutic implications

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells

The role of p53 in cancer drug resistance and targeted chemotherapy

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Postibrutinib outcomes in patients with mantle cell lymphoma.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.

Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.

Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.

P304

28547-28560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25558

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29983879

http://www.w3.org/2001/XMLSchema#string

P932

6033370

http://www.w3.org/2001/XMLSchema#string